Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria
Authors:
- 2 June 2024
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 211, 115345
Abstract
No abstract availableKeywords
This publication has 224 references indexed in Scilit:
- Study on the antibacterial effect of CuO nanoparticles on Klebsiella pneumonia bacteria: Efficient treatment for colorectal cancerBiotechnology and Applied Biochemistry, 2023
- A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer TherapyAdvanced Science, 2023
- Microbiota in Tumors: From Understanding to ApplicationAdvanced Science, 2022
- Hydrogen Sulfide: An Emerging Precision Strategy for Gas TherapyAdvanced Healthcare Materials, 2021
- Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancerHead & Neck, 2021
- Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer TumorsJAMA Network Open, 2020
- Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver MetastasisAdvanced Materials, 2018
- Lithocholic Acid Stimulates IL-8 Expression in Human Colorectal Cancer Cells Via Activation of Erk1/2 MAPK and Suppression of STAT3 ActivityJournal of Cellular Biochemistry, 2017
- Nanoparticles in the clinicBioengineering & Translational Medicine, 2016
- Ursodeoxycholic acid inhibits interleukin beta 1 and deoxycholic acid‐induced activation of NF‐κB and AP‐1 in human colon cancer cellsInternational Journal of Cancer, 2005